FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107962132> ?p ?o ?g. }

• W2107962132 endingPage "33" @default.
• W2107962132 startingPage "25" @default.
• W2107962132 abstract "Cluster headache and trigeminal neuralgia are relatively rare but debilitating neurologic conditions. Although they are clinically and diagnostically distinct from migraine, many of the same pharmacologic agents are used in their management. For many patients, the attacks are so frequent and severe that abortive therapy is often ineffective; therefore, chronic preventive therapy is necessary for adequate pain control. Cluster headache and trigeminal neuralgia have several distinguishing clinical features. Cluster headache is predominantly a male disorder; trigeminal neuralgia is more prevalent in women. Individuals with cluster headaches often develop their first attack before age 25; most patients with trigeminal neuralgia are between age 50 and 70. Cluster headaches are strongly associated with tobacco smoking and triggered by alcohol consumption; trigeminal neuralgia can be triggered by such stimuli as shaving and toothbrushing. Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve. Cluster headache is unique because of its associated autonomic symptoms. Although the pathophysiology of cluster headache and trigeminal neuralgia are not completely understood, both appear to have central primary processes, and these findings have prompted investigations of the effectiveness of the newer antiepileptic drugs for cluster headache prevention and for the treatment of trigeminal neuralgia. The traditional antiepileptic drugs phenytoin and carbamazepine have been used for the treatment of trigeminal neuralgia for a number of years, and while they are effective, they can sometimes cause central nervous system effects such as drowsiness, ataxia, somnolence, and diplopia. Reports of studies in small numbers of patients or individual case studies indicate that the newer antiepileptic drugs are effective in providing pain relief for trigeminal neuralgia and cluster headache sufferers, with fewer central nervous system side effects. Divalproex has been shown to provide effective pain control and to reduce cluster headache frequency by more than half in episodic and chronic cluster headache sufferers. Topiramate demonstrated efficacy in a study of 15 patients, with a mean time to induction of cluster headache remission of 1.4 weeks (range, 1 day to 3 weeks). In the treatment of trigeminal neuralgia, gabapentin has been shown to be effective in an open-label study. When added to an existing but ineffective regimen of carbamazepine or phenytoin, lamotrigine provided improved pain relief; it also may work as monotherapy. Topiramate provided a sustained analgesic effect when administered to patients with trigeminal neuralgia. The newer antiepileptic drugs show considerable promise in the management of cluster headache and trigeminal neuralgia." @default.
• W2107962132 created "2016-06-24" @default.
• W2107962132 creator A5057371516 @default.
• W2107962132 date "2001-11-01" @default.
• W2107962132 modified "2023-10-17" @default.
• W2107962132 title "Antiepileptic Drugs in the Management of Cluster Headache and Trigeminal Neuralgia" @default.
• W2107962132 cites W160855862 @default.
• W2107962132 cites W1776293395 @default.
• W2107962132 cites W1969844022 @default.
• W2107962132 cites W1976341842 @default.
• W2107962132 cites W1979145649 @default.
• W2107962132 cites W1980212139 @default.
• W2107962132 cites W1980214037 @default.
• W2107962132 cites W1982160289 @default.
• W2107962132 cites W1997618593 @default.
• W2107962132 cites W2000476601 @default.
• W2107962132 cites W2001257231 @default.
• W2107962132 cites W2003841602 @default.
• W2107962132 cites W2007969772 @default.
• W2107962132 cites W2010482304 @default.
• W2107962132 cites W2017155646 @default.
• W2107962132 cites W2037275755 @default.
• W2107962132 cites W2098813714 @default.
• W2107962132 cites W2099005403 @default.
• W2107962132 cites W2119093004 @default.
• W2107962132 cites W2135255451 @default.
• W2107962132 cites W2166825256 @default.
• W2107962132 cites W2413346493 @default.
• W2107962132 doi "https://doi.org/10.1046/j.1526-4610.2001.01154-5.x" @default.
• W2107962132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11903537" @default.
• W2107962132 hasPublicationYear "2001" @default.
• W2107962132 type Work @default.
• W2107962132 sameAs 2107962132 @default.
• W2107962132 citedByCount "52" @default.
• W2107962132 countsByYear W21079621322012 @default.
• W2107962132 countsByYear W21079621322013 @default.
• W2107962132 countsByYear W21079621322015 @default.
• W2107962132 countsByYear W21079621322016 @default.
• W2107962132 countsByYear W21079621322021 @default.
• W2107962132 crossrefType "journal-article" @default.
• W2107962132 hasAuthorship W2107962132A5057371516 @default.
• W2107962132 hasConcept C118552586 @default.
• W2107962132 hasConcept C141071460 @default.
• W2107962132 hasConcept C2777107010 @default.
• W2107962132 hasConcept C2777397368 @default.
• W2107962132 hasConcept C2777942821 @default.
• W2107962132 hasConcept C2778186239 @default.
• W2107962132 hasConcept C2778541695 @default.
• W2107962132 hasConcept C2779253243 @default.
• W2107962132 hasConcept C2780016216 @default.
• W2107962132 hasConcept C2780355897 @default.
• W2107962132 hasConcept C2780966972 @default.
• W2107962132 hasConcept C42219234 @default.
• W2107962132 hasConcept C71924100 @default.
• W2107962132 hasConceptScore W2107962132C118552586 @default.
• W2107962132 hasConceptScore W2107962132C141071460 @default.
• W2107962132 hasConceptScore W2107962132C2777107010 @default.
• W2107962132 hasConceptScore W2107962132C2777397368 @default.
• W2107962132 hasConceptScore W2107962132C2777942821 @default.
• W2107962132 hasConceptScore W2107962132C2778186239 @default.
• W2107962132 hasConceptScore W2107962132C2778541695 @default.
• W2107962132 hasConceptScore W2107962132C2779253243 @default.
• W2107962132 hasConceptScore W2107962132C2780016216 @default.
• W2107962132 hasConceptScore W2107962132C2780355897 @default.
• W2107962132 hasConceptScore W2107962132C2780966972 @default.
• W2107962132 hasConceptScore W2107962132C42219234 @default.
• W2107962132 hasConceptScore W2107962132C71924100 @default.
• W2107962132 hasIssue "s1" @default.
• W2107962132 hasLocation W21079621321 @default.
• W2107962132 hasLocation W21079621322 @default.
• W2107962132 hasOpenAccess W2107962132 @default.
• W2107962132 hasPrimaryLocation W21079621321 @default.
• W2107962132 hasRelatedWork W1979976727 @default.
• W2107962132 hasRelatedWork W1998205542 @default.
• W2107962132 hasRelatedWork W2460864373 @default.
• W2107962132 hasRelatedWork W2461458442 @default.
• W2107962132 hasRelatedWork W2560107378 @default.
• W2107962132 hasRelatedWork W2736131834 @default.
• W2107962132 hasRelatedWork W2788241266 @default.
• W2107962132 hasRelatedWork W3030264022 @default.
• W2107962132 hasRelatedWork W4239432388 @default.
• W2107962132 hasRelatedWork W4248014232 @default.
• W2107962132 hasVolume "41" @default.
• W2107962132 isParatext "false" @default.
• W2107962132 isRetracted "false" @default.
• W2107962132 magId "2107962132" @default.
• W2107962132 workType "article" @default.